Enanta Pharmaceuticals | DEBITO





DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Amgen USD 54.59B 1.62B 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Incyte USD 40.41M 855K 2025-12
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
Merck USD 41.37B 5.97B 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09


Enanta Pharmaceuticals DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.